D tumoroid models transform cancer research, accurately reflecting tumor biology and enabling effective drug testing and ...

However, the potential of immunotherapy for endometrial cancer (EC) with POLE mutations remains underexplored. Conclusions: Our study uncovers the pronounced immunogenicity of POLE-mutant EC and ...

IMA-402 is under clinical development by Immatics and currently in Phase II for Uterine Cancer. According to GlobalData, Phase II drugs for Uterine Cancer have a 30% phase transition success rate ...

Ellisen, MGH Cancer Center, CPZN-4204, 185 Cambridge Street, Boston, MA 02114. E-mail: [email protected] Clin Cancer Res 2025;XX:XX–XX R.O. Abelman, B. Wu, and H. Barnes contributed equally to this ...

1Department of Oncology, University of Oxford, Oxford, United Kingdom. *Corresponding Author: Connor E. Woolley, Department of Oncology, University of Oxford, Old Road Campus Research Building, ...

Compared with chemotherapy alone, the addition of radiation to chemotherapy did not improve overall or recurrence-free survival in patients with locally advanced endometrial cancer, a new phase 3 ...

By comparing genetic mutations to epigenetic modifications, they found that mutations were predictably correlated with changes in DNA methylation, one type of epigenetic modification.

Health authorities and researchers are closely examining the mutations found in the virus extracted from the 65-year-old man, who was infected through contact with backyard birds contaminated by ...

In addition, Black people are twice as likely as white people to die of prostate, stomach and uterine corpus cancers. Black people are also 50% more likely to die from cervical cancer, which is ...

While a persistent, low-grade fever can occur with many different types of cancer, it is not diagnostic of cancer on its own. A fever can accompany a great many illnesses, the vast majority of which ...